Tempest Therapeutics TPST
NASDAQ TPST
$0.80 -0.11 (-11.70%)
At close: Sep 10, 2026 · 4:00 PM EDT

Tempest Therapeutics (TPST) Net Shares Issued and Repurchased (2011 - 2015)

Tempest Therapeutics' (TPST) quarterly Net Shares Issued and Repurchased came in at $419500.0 in Q1 2015, up 11.24% year-over-year from $377098.0 in Q1 2014, and up 109.75% quarter-over-quarter from $200000.0 in Q4 2014.

Analysis

Tempest Therapeutics (TPST) Net Shares Issued and Repurchased (2011 - 2015) Analysis & Trends

Tempest Therapeutics has disclosed Net Shares Issued and Repurchased across 5 years of filings, most recently posting $419500.0 for Q1 2015.

  • In Q1 2015, Net Shares Issued and Repurchased rose 11.24% year-over-year to $419500.0; the TTM figure through Mar 2015 stood at $419500.0 (up 11.24% YoY), while the FY2014 annual figure was $2.5 million, up 60.3% from the prior year.
  • Net Shares Issued and Repurchased came in at $419500.0 for Q1 2015 at Tempest Therapeutics, up from $200000.0 in the prior quarter.
  • In the past five years, Net Shares Issued and Repurchased ranged from a high of $1.5 million in Q4 2013 to a low of $60799.0 in Q1 2012.
  • Average Net Shares Issued and Repurchased over 5 years is $395900.3, with a median of $358205.5 recorded in 2012.
  • Year-over-year, Net Shares Issued and Repurchased soared 619.65% in 2013 and slumped 86.99% in 2014.
  • Over 5 years, Net Shares Issued and Repurchased stood at $165339.0 in 2011, then surged by 105.22% to $339313.0 in 2012, then jumped by 353.02% to $1.5 million in 2013, then tumbled by 86.99% to $200000.0 in 2014, then soared by 109.75% to $419500.0 in 2015.
  • Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $419500.0 in Q1 2015, $200000.0 in Q4 2014, and $500000.0 in Q3 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - -
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn -
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn -
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn -
6 Beam Therapeutics 2.55 Bn 2.55 Bn - -
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn -
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn -
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn -
10 Tempest Therapeutics 3.35 Mn 2.55 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 419,500.00
Dec 31, 2014 200,000.00
Sep 30, 2014 500,000.00
Jun 30, 2014 500,000.00
Mar 31, 2014 377,098.00
Dec 31, 2013 1.54 Mn
Mar 31, 2013 437,542.00
Dec 31, 2012 339,313.00
Sep 30, 2012 141,000.00
Jun 30, 2012 73,041.00
Mar 31, 2012 60,799.00
Dec 31, 2011 165,339.00